Search Results 2161-2170 of 40558 for Two-phase

  1. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer - Mayo Clinic

    ... Phase 1a dose finding study (TARA-002-101-Ph1a). This Phase 2 study includes participants with CIS NMIBC (± Ta/T1) with active disease (defined as disease ...

  3. A Dose-Ranging Study to Evaluate the Effectiveness and Safety of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex - Mayo Clinic

    Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  4. The eMESH 1 Feasibility Study - Clinical Trials

    Overview. Tab Title Description. Study typeInterventional Study phase1/2. Study ... two systems; Single Vessel Cohort: Requires CABG surgery with a SVG to ...

  5. Chordoma - Symptoms and causes - Mayo Clinic

    But they often grow in two locations. The first ... Sometimes metastatic chordoma may be called advanced chordoma or end-stage chordoma. ... A prospective phase I/ ...

  6. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. A Study to Evaluate RP1 Monotherapy and Combined with Nivolumab - Mayo Clinic

    ... Phase 2 dose (RP2D), as well as to evaluate preliminary effectiveness. Participation eligibility. Participant eligibility includes age, gender, type and ...

  8. Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma - Mayo Clinic

    Study phase. 0. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety, side ... Splenectomy (Phase 2 portion of the study only); Known HIV positive status ...

  10. Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...